Su Yeon Lim

538 total citations
26 papers, 411 citations indexed

About

Su Yeon Lim is a scholar working on Molecular Biology, Immunology and Pharmaceutical Science. According to data from OpenAlex, Su Yeon Lim has authored 26 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Immunology and 6 papers in Pharmaceutical Science. Recurrent topics in Su Yeon Lim's work include Immunotherapy and Immune Responses (7 papers), Advancements in Transdermal Drug Delivery (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Su Yeon Lim is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Advancements in Transdermal Drug Delivery (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Su Yeon Lim collaborates with scholars based in South Korea, United States and Portugal. Su Yeon Lim's co-authors include Ji Hoon Jeong, Min Sang Lee, Nak Won Kim, Joon Cheol Park, Yue Yin, Jong Han Lee, Doo Sung Lee, Jung Eun Lee, Yong Taik Lim and Huu Thuy Trang Duong and has published in prestigious journals such as ACS Nano, Biomaterials and Cancer Research.

In The Last Decade

Su Yeon Lim

22 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Su Yeon Lim South Korea	9	121	112	99	75	72	26	411
Keerthie Dissanayake Estonia	13	28 0.2×	528 4.7×	247 2.5×	36 0.5×	43 0.6×	23	744
Kasun Godakumara Estonia	12	28 0.2×	562 5.0×	280 2.8×	36 0.5×	52 0.7×	27	756
Getnet Midekessa Estonia	8	28 0.2×	368 3.3×	99 1.0×	36 0.5×	8 0.1×	13	515
Zhongyi Gu China	8	57 0.5×	129 1.2×	29 0.3×	73 1.0×	15 0.2×	9	559
Maryam Derakhshan Iran	12	14 0.1×	272 2.4×	83 0.8×	68 0.9×	34 0.5×	30	636
Einat Cohen-Sela Israel	6	157 1.3×	127 1.1×	47 0.5×	177 2.4×	7 0.1×	6	441
Fangfang Nan China	10	26 0.2×	103 0.9×	59 0.6×	41 0.5×	20 0.3×	14	435
Zhouxue Wu China	13	54 0.4×	150 1.3×	27 0.3×	272 3.6×	10 0.1×	24	572
Celia N. Sánchez‐Domínguez Mexico	13	12 0.1×	115 1.0×	90 0.9×	56 0.7×	4 0.1×	38	444
Amanda Templeton United States	7	36 0.3×	97 0.9×	77 0.8×	108 1.4×	15 0.2×	8	396

Countries citing papers authored by Su Yeon Lim

Since Specialization

Citations

This map shows the geographic impact of Su Yeon Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Yeon Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Yeon Lim more than expected).

Fields of papers citing papers by Su Yeon Lim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su Yeon Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Yeon Lim. The network helps show where Su Yeon Lim may publish in the future.

Co-authorship network of co-authors of Su Yeon Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Su Yeon Lim. A scholar is included among the top collaborators of Su Yeon Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su Yeon Lim. Su Yeon Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lim, Su Yeon, Hyun‐Ouk Kim, Suk‐Jin Ha, et al.. (2025). Combination Strategies with HSP90 Inhibitors in Cancer Therapy: Mechanisms, Challenges, and Future Perspectives. Pharmaceuticals. 18(8). 1083–1083.

Lim, Su Yeon, Liu Pin, J.H. Jung, et al.. (2025). Reshaping Tumor-Lymph Node Immune Axis via Targeted Lymphatic Delivery of Dual-Functional Immune Modulator for Enhanced Cancer Immunotherapy. ACS Central Science. 11(11). 2074–2086.

Kwak, Jae‐Yong, Myung Su Lim, Su Yeon Lim, et al.. (2025). Advances in PCL, PLA, and PLGA-Based Technologies for Anticancer Drug Delivery. Pharmaceutics. 17(10). 1354–1354. 1 indexed citations

Lim, Su Yeon, Seungmin Han, Yeo Hyung Kim, et al.. (2025). Advanced breast cancer immunotherapy: Surface modification of NK cells for embedding antibody-drug conjugates. Biomedicine & Pharmacotherapy. 189. 118245–118245.

Kang, In Man, Su Yeon Lim, Yesol Kim, et al.. (2025). Local delivery of IL-12 mRNA and indoximod prodrug potentiates antitumor immunity by increasing T cell effector function. Journal of Controlled Release. 385. 113970–113970. 1 indexed citations

Jung, Jae Min, Min Sang Lee, Jung Eun Lee, et al.. (2025). Bioengineered metastatic cancer nanovaccine with a TLR7/8 agonist for needle-free intranasal immunization. Biomaterials. 321. 123331–123331. 1 indexed citations

Lim, Su Yeon, Min Sang Lee, Jihyun Lee, et al.. (2025). Mechanobiologically Engineered Mimicry of Extracellular Vesicles for Improved Systemic Biodistribution and Anti‐Inflammatory Treatment Efficacy in Rheumatoid Arthritis. Advanced Healthcare Materials. 14(25). e2500795–e2500795. 1 indexed citations

Lim, Su Yeon, et al.. (2024). Synergistic Chemo-Immunotherapy: Recombinant Fusion Protein-Based Surface Modification of NK Cell for Targeted Cancer Treatment. Pharmaceutics. 16(9). 1189–1189. 3 indexed citations

Lim, Su Yeon, Sugyeong Kim, Hong Bin Kim, et al.. (2024). Development of Tat-fused drug binding protein to improve anti-cancer effect of mammalian target of rapamycin inhibitors. Biotechnology and Bioprocess Engineering. 29(2). 303–312.

10.

Choi, Jaewon, Hong Bin Kim, Su Yeon Lim, et al.. (2024). Recent advances in microbial and enzymatic engineering for the biodegradation of micro- and nanoplastics. RSC Advances. 14(14). 9943–9966. 29 indexed citations

11.

Lim, Su Yeon, et al.. (2024). Abstract 5572: Microneedle-guided lymphatic delivery of a natural immune modulator toxin for enhanced cancer immunotherapy. Cancer Research. 84(6_Supplement). 5572–5572. 1 indexed citations

12.

Chien, Pham Ngoc, et al.. (2022). Nanomicelle-generating Microneedles Loaded With Tranilast for Treatment of Hypertrophic Scars in a Rabbit Model. In Vivo. 36(4). 1734–1744. 8 indexed citations

13.

Kim, Nak Won, et al.. (2022). Chemoattractant releasing microneedles for enhanced DNA vaccination. Journal of Industrial and Engineering Chemistry. 117. 109–116. 1 indexed citations

14.

Lim, Su Yeon, et al.. (2022). Microneedle‐Directed Drug Delivery to Tumor‐Draining Lymph Node for Synergistic Combination Chemoimmunotherapy for Metastatic Cancer. Advanced Therapeutics. 5(4). 7 indexed citations

15.

Lee, Min Sang, et al.. (2021). Sustained-Release Microspheres of Rivoceranib for the Treatment of Subfoveal Choroidal Neovascularization. Pharmaceutics. 13(10). 1548–1548. 4 indexed citations

16.

Yin, Yue, Min Sang Lee, Jung Eun Lee, et al.. (2019). Effective systemic siRNA delivery using dual-layer protected long-circulating nanohydrogel containing an inorganic core. Biomaterials Science. 7(8). 3297–3306. 4 indexed citations

17.

Lee, Jung Eun, Yue Yin, Su Yeon Lim, et al.. (2019). Enhanced Transfection of Human Mesenchymal Stem Cells Using a Hyaluronic Acid/Calcium Phosphate Hybrid Gene Delivery System. Polymers. 11(5). 798–798. 24 indexed citations

18.

Lee, Min Sang, Kyuri Lee, Min Woo Nam, et al.. (2018). Natural deep eutectic solvents as a storage medium for human interferon-α2: a green and improved strategy for room-temperature biologics. Journal of Industrial and Engineering Chemistry. 65. 343–348. 33 indexed citations

19.

Lee, Min Sang, Nak Won Kim, Jung Eun Lee, et al.. (2018). Targeted cellular delivery of robust enzyme nanoparticles for the treatment of drug-induced hepatotoxicity and liver injury. Acta Biomaterialia. 81. 231–241. 18 indexed citations

20.

Lim, Su Yeon, et al.. (2009). Induction of growth inhibition and apoptosis in human endometrial cancer cells by histone deacetylase inhibitors. Obstetrics & Gynecology Science. 52(9). 911–919. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact